https://www.fhcrc.org/en/news/releases/rss2013-12-12T23:36:57.781ZNews Releases RSS FeedAdobe Experience ManagerInternational study demonstrates protein-measurement technique’s potential to standardize quantification of the entire human proteome - Fred Hutchinson Cancer Research CenterAn international team of scientists led by Fred Hutchinson Cancer Research Center cancer proteomics expert Amanda Paulovich, M.D., has demonstrated the feasibility of large-scale, standardized protein measurements, which are necessary for validation of disease biomarkers and drug targets. https://www.fhcrc.org/en/news/releases/2013/12/international-study-demonstrates-protein-measurement-techniques-potential-to-standardize-quantification-of-the-entire-human-proteome2013-12-08T22:30:00.000Z2013-12-08T22:30:00.000ZPredicting ovarian cancer by counting tumor-attacking immune cellsFred Hutch scientists have developed a new method for counting a special class of cancer-fighting cells – called tumor-infiltrating T lymphocytes, or TILs – reliably, quickly and cheaply in patients with early stage and advanced ovarian cancer. https://www.fhcrc.org/en/news/releases/2013/11/ovarian-cancer-immune-cells2013-12-04T22:02:16.000Z2013-12-04T22:02:16.000ZLeading cancer research centers team up to launch biotech startup focused on cancer immunotherapyThe Fred Hutchinson Cancer Research Center and Memorial Sloan-Kettering Cancer Center, along with pediatric partner Seattle Children’s Research Institute, have joined forces to launch Juno Therapeutics Inc., a new biotechnology company focused on bringing forward novel immunotherapies for cancer.https://www.fhcrc.org/en/news/releases/2013/11/biotech-startup-cancer-immunotherapy2013-12-04T21:44:09.000Z2013-12-04T21:44:09.000ZNew insights into cancer evolution help define screening window of opportunityNew insights into cancer evolution help define screening window of opportunity A new appreciation of the genetic changes that occur as precancerous cells turn malignant could help researchers design new screening strategies
https://www.fhcrc.org/en/news/releases/2013/11/cancer-evolution-define-screening2013-12-03T18:41:08.000Z2013-12-03T18:41:08.000ZStudy finds link between allergies and increased risk of blood cancers in women - Fred Hutchinson Cancer Research CenterA team of scientists looking into the interplay of the immune system and cancer have found a link between a history of airborne allergies – in particular to plants, grass and trees – with risk of blood cancers in women. Notably, the study did not find the same association in men, which suggests a possible gender-specific role in chronic stimulation of the immune system that may lead to the development of hematologic cancers.
https://www.fhcrc.org/en/news/releases/2013/11/study-finds-link-between-allergies-and-increased-risk-of-blood-cancers-in-women2013-11-22T05:00:00.000Z2013-11-22T05:00:00.000ZHIV vaccine researcher Julie McElrath receives Women of Influence Award - Fred Hutchinson Cancer Research CenterJulie McElrath, M.D., Ph.D., an HIV vaccine researcher at Fred Hutchinson Cancer Research Center, is among 16 recipients of Puget Sound Business Journal’s 2013 Women of Influence Award. She accepted the honor last night at an award ceremony at the Hyatt Regency in Bellevue, Wash.https://www.fhcrc.org/en/news/releases/2013/11/hiv-vaccine-researcher-julie-mcelrath-receives-women-of-influence-award2013-11-14T08:00:00.000Z2013-11-14T08:00:00.000ZSeattle Mariners outfielder/designated hitter Raúl Ibañez named Hutch Award® winner - Fred Hutchinson Cancer Research CenterRaúl Ibañez, an outfielder and designated hitter for the Seattle Mariners who is considered one of the most consistent and professional players in Major League Baseball, will receive the 49th annual Hutch Award® at a Jan. 30 luncheon at Seattle’s Safeco Field.https://www.fhcrc.org/en/news/releases/2013/11/seattle-mariners-outfielder-designated-hitter-raul-ibanez-named-hutch-award-winner2013-11-05T17:50:17.000Z2013-11-05T17:50:17.000ZEndometriosis risk linked to two pesticides - Fred Hutchinson Cancer Research CenterA Fred Hutchinson Cancer Research Center-led study has found that two organochlorine pesticides are associated with an increased risk of endometriosis, a condition that affects up to 10 percent of reproductive-age women. Specifically, researchers observed that women with higher exposures to two such pesticides, beta-hexachlorocyclohexane and mirex, had a 30- to 70-percent increase in endometriosis risk.https://www.fhcrc.org/en/news/releases/2013/11/endometriosis-risk-linked-to-two-pesticides2013-11-05T05:00:00.000Z2013-11-05T05:00:00.000ZGame It Forward’s ‘Quingo’ game for charity will be available for iPhone - Fred Hutchinson Cancer Research Centerhttps://www.fhcrc.org/en/news/releases/2013/10/game-it-forwards-quingo-game-for-charity-will-be-available-for-iphone2013-10-30T17:22:15.000Z2013-10-30T17:22:15.000ZInaugural Obliteride sets Northwest fundraising record - Fred Hutchinson Cancer Research CenterThe inaugural Obliteride was a huge success. In its first year, Obliteride raised more money for a local organization than any other bicycling fundraiser in the Northwest. The inaugural ride raised $1.9 million that will go directly to lifesaving research at Fred Hutchinson Cancer Research Center in Seattle. https://www.fhcrc.org/en/news/releases/2013/10/inaugural_obliteride_sets_northwest_fundraising_record2013-10-23T21:49:51.000Z2013-10-23T21:49:51.000ZFred Hutchinson Cancer Research Center opens HIV-vaccine lab in South Africa - Fred Hutchinson Cancer Research Centerred Hutchinson Cancer Research Center tomorrow will celebrate the grand opening of a state-of-the-art HIV vaccine laboratory in Cape Town, South Africa. The lab is part of the HIV Vaccine Trials Network, which is headquartered at Fred Hutch in Seattle and is the world’s largest network dedicated to testing vaccine candidates for the prevention of HIV. https://www.fhcrc.org/en/news/releases/2013/10/fred_hutchinson_cancer_research_center_opens_hiv_vaccine_lab_in_south_africa2013-10-22T23:15:11.000Z2013-10-22T23:15:11.000ZFrederick Appelbaum elected to Institue of Medicine - Fred Hutchinson Cancer Research CenterFrederick R. Appelbaum, M.D., executive vice president and deputy director of Fred Hutchinson Cancer Research Center, has been elected to the Institute of Medicine. Election to IOM is considered to be one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to science.https://www.fhcrc.org/en/news/releases/2013/10/frederick-appelbaum-elected-to-institue-of-medicine-fred-hutchinson-cancer-research-center2013-10-21T18:04:39.000Z2013-10-21T18:04:39.000Z10 baseball players nominated for 49th annual Hutch Award - Fred Hutchinson Cancer Research CenterTen Major League Baseball players have been nominated for the 49th annual Hutch Award®, to be given Jan. 30 at Safeco Field in Seattle. The award, launched a year after Hutchinson’s death by three of his friends, is presented annually at the Hutch Award Luncheon which raises funds for cancer research at Fred Hutchinson Cancer Research Center. https://www.fhcrc.org/en/news/releases/2013/10/hutch-award-nominees2013-10-15T23:07:56.000Z2013-10-15T23:07:56.000ZResearchers identify four genetic variants that are linked to esophageal cancer and its precursor, Barrett’s esophagus - Fred Hutchinson Cancer Research CenterAn international consortium co-led by researchers at Fred Hutchinson Cancer Research Center and the QIMR Berghofer Medical Research Institute in Australia has identified four genetic variants associated with an increased risk of esophageal cancer and its precursor, a condition called Barrett’s esophagus.https://www.fhcrc.org/en/news/releases/2013/10/researchers-identify-four-genetic-variants-linked-to-esophageal-cancer-and-precursor-barretts-esophagus2013-10-13T17:00:00.000Z2013-10-13T17:00:00.000ZResearchers discover a new way that influenza can infect cells - Fred Hutchinson Cancer Research CenterScientists at Fred Hutchinson Cancer Research Center have uncovered a new mechanism by which influenza can infect cells – a finding that ultimately may have implications for immunity against the flu.https://www.fhcrc.org/en/news/releases/2013/09/researchers-influenza-infect-cells2013-09-23T19:36:57.000Z2013-09-23T19:36:57.000ZSix charities will receive donations from Game It Forward’s first-release ‘Quingo,’ which combines trivia questions and bingo - Fred Hutchinson Cancer Research CenterSix charities, including five based in Seattle, will receive funds from a new iPad game created by local startup Game It Forward. “Quingo” combines the fun of bingo with the challenge of trivia questions and is now available for free on iTunes.https://www.fhcrc.org/en/news/releases/2013/09/six-charities-will-receive-donations-from-game-it-forwards-quingo2013-09-19T15:00:00.000Z2013-09-19T15:00:00.000ZFred Hutch receives $11.3M NCI grant renewal to lead Pacific Northwest prostate cancer research consortium - Fred Hutchinson Cancer Research CenterThe National Cancer Institute, a branch of the National Institutes of Health, has awarded an $11.3 million, five-year competitive grant renewal to Fred Hutchinson Cancer Research Center for its continued leadership of a multi-center prostate cancer research consortium, which was first funded in 2002.
Known as the Pacific Northwest Prostate Cancer SPORE (SPORE is short for Specialized Programs of Research Excellence), the consortium aims to unravel the molecular mechanisms underlying the development and progression of prostate cancer and to develop new therapeutic strategies that use precision-medicine approaches to improve survival and reduce treatment-related side effects.https://www.fhcrc.org/en/news/releases/2013/09/nci-grant-renewal-to-lead-pacific-northwest-prostate-cancer-research-consortium2013-09-18T18:45:35.000Z2013-09-18T18:45:35.000ZFrederick Appelbaum, a world expert in blood cancers, named deputy director of Fred Hutchinson Cancer Research Center - Fred Hutchinson Cancer Research CenterFrederick R. Appelbaum, M.D., a world expert in the research and treatment of blood cancers who for the past two decades has served as senior vice president and director of the Clinical Research Division at Fred Hutchinson Cancer Research Center, has been named executive vice president and deputy director of Fred Hutch. His appointment is effective immediately.https://www.fhcrc.org/en/news/releases/2013/09/frederick-appelbaum-named-dupty-director2013-09-17T18:41:00.000Z2013-09-17T18:41:00.000ZStudy sheds light on genetics of how and why fish swim in schools - Fred Hutchinson Cancer Research CenterHow and why fish swim in schools has long fascinated biologists looking for clues to understand the complexities of social behavior. A new study by a team of researchers at Fred Hutchinson Cancer Research Center may help provide some insight.https://www.fhcrc.org/en/news/releases/2013/09/study-genetics-fish-swim2013-09-12T16:00:00.000Z2013-09-12T16:00:00.000ZPhysician scientist receives $250,000 grant from Hyundai Hope On Wheels in honor of National Childhood Cancer Awareness Month - Fred Hutchinson Cancer Research CenterHyundai Hope On Wheels® and Seattle-area Hyundai dealers today will award a physician scientist at Fred Hutchinson Cancer Research Center with a $250,000 Hyundai Hope Grant for pediatric cancer research. The funds will support Dr. Ann Dahlberg’s research, which is focused on decreasing life-threatening infections in patients with high-risk leukemias. https://www.fhcrc.org/en/news/releases/2013/09/hyundai-hope-on-wheels-grant-childhood-cancer-awareness2013-09-10T20:00:00.000Z2013-09-10T20:00:00.000Z